Eli Lilly to Acquire AtaiBeckley for up to $3.8B, Betting Big on Psychedelic Medicine
The pharma giant is buying the clinical-stage biotech behind BPL-003 — a synthetic 5-MeO-DMT for treatment-resistant depression — in a deal that pushes psychedelic therapy firmly into the mainstream drug industry.
Editorial Team · 1 min read
Neko Health Raises $700M Series C Ahead of US Launch
The preventive-scanning company co-founded by Spotify's Daniel Ek has raised one of European health tech's largest-ever rounds — backed by Lightspeed and a long list of high-profile names including Mark Zuckerberg — as it prepares to open in New York.
Editorial Team · 4 min read
Functional-Drinks Brand Reformed Raises $22M Series A to Enter the US
The UK startup turns instant coffee and matcha into functional-wellness products — with collagen, creatine, and mushrooms mixed in. Two years in, it says it's already at ~$70M in annual revenue.
Editorial Team · 3 min read
A new syndicate, Peers Capital, launches to fund preventive health at the earliest stage
The investor group is backing pre-seed and seed founders across diagnostics, recovery, and longevity through a deal-by-deal model — and they have already closed its first investments
William Ferreira Andrén · 4 min read